Psychoneurobiology Research and Personalized Treatment of Schizophrenia
Schizophrenia is a common disease characterized by psychotic symptoms (e.g., delusion, hallucinations, blunted affect) and disturbances of cognitive function (e.g., memory, abstraction, attention). If not treated properly, patients may experience serious consequences in terms of social function. Muc...
Format: | eBook |
---|---|
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Subjects: | |
Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
LEADER | 03888namaa2201069uu 4500 | ||
---|---|---|---|
001 | doab78772 | ||
003 | oapen | ||
005 | 20220224 | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 220224s2022 xx |||||o ||| 0|eng d | ||
020 | |a 9783036528588 | ||
020 | |a 9783036528595 | ||
020 | |a books978-3-0365-2858-8 | ||
024 | 7 | |a 10.3390/books978-3-0365-2858-8 |2 doi | |
040 | |a oapen |c oapen | ||
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
720 | 1 | |a Sumiyoshi, Tomiki |4 edt | |
720 | 1 | |a Sumiyoshi, Tomiki |4 oth | |
245 | 0 | 0 | |a Psychoneurobiology Research and Personalized Treatment of Schizophrenia |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 online resource (133 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
520 | |a Schizophrenia is a common disease characterized by psychotic symptoms (e.g., delusion, hallucinations, blunted affect) and disturbances of cognitive function (e.g., memory, abstraction, attention). If not treated properly, patients may experience serious consequences in terms of social function. Much endeavor in several disciplines of medical science has been made to overcome the paucity of effective treatments for unmet needs, including cognitive impairment associated with schizophrenia.This Book, contributed by experts from various regions of the globe, provides up-to-date information to facilitate the development of personal therapeutics for this enigmatic illness. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine and Nursing |2 bicssc | |
653 | |a antipsychotics | ||
653 | |a at risk mental state | ||
653 | |a body mass index | ||
653 | |a cannabis | ||
653 | |a clinical high-risk | ||
653 | |a cognition | ||
653 | |a cognitive insight | ||
653 | |a complement | ||
653 | |a CX3CR1 | ||
653 | |a developmental disorders | ||
653 | |a diagnosis | ||
653 | |a dorsal striatum | ||
653 | |a event-related potentials | ||
653 | |a experiment | ||
653 | |a facial expression recognition | ||
653 | |a first-episode psychosis | ||
653 | |a genes | ||
653 | |a gyrification | ||
653 | |a latency | ||
653 | |a magnetic resonance imaging | ||
653 | |a medial prefrontal cortex | ||
653 | |a medication | ||
653 | |a mental disorders | ||
653 | |a metabolic syndrome | ||
653 | |a metabolism | ||
653 | |a metacognitive training | ||
653 | |a microglia | ||
653 | |a MTREX | ||
653 | |a n/a | ||
653 | |a needs survey | ||
653 | |a neurodevelopment | ||
653 | |a neuromodulation | ||
653 | |a olfactory neuroepithelium | ||
653 | |a optogenetics | ||
653 | |a P300 | ||
653 | |a pharmacogenetics | ||
653 | |a piccolo | ||
653 | |a presynaptic cytomatrix protein | ||
653 | |a proteomics | ||
653 | |a psychosis | ||
653 | |a quality of life | ||
653 | |a RNA | ||
653 | |a schizophrenia | ||
653 | |a schizotypal disorder | ||
653 | |a serotonin | ||
653 | |a sessions | ||
653 | |a social cognition | ||
653 | |a social function | ||
653 | |a social functioning | ||
653 | |a superior temporal gyrus | ||
653 | |a superior temporal sulcus | ||
653 | |a synaptic pruning | ||
653 | |a systematic review | ||
653 | |a test battery | ||
653 | |a transcranial direct current stimulation (tDCS) | ||
653 | |a weight gain | ||
653 | |a ZNF326 | ||
793 | 0 | |a DOAB Library. | |
856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/78772 |7 0 |z Open Access: DOAB: description of the publication |
856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/4865 |7 0 |z Open Access: DOAB, download the publication |